IDH2 and cancer: The missense and heterozygous cancer-associated mutations typically occur at Arginine 132 in IDH1 and Arginine 172 in IDH2, impairing the ability of mutant IDH to bind with isocitrate (Yan et al., 2009; Pirozzi and Yan, 2021).